Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence TASDPLDTLGSEGALSPGGVASLLRLPRGCGEQTMI
Primary information
sequence IDSeq_8074
Peptide sequenceTASDPLDTLGSEGALSPGGVASLLRLPRGCGEQTMI
CancerPDF_ID CancerPDF_ID7353, CancerPDF_ID7354, CancerPDF_ID7355,
PMID24982608,24982608,24982608
Protein NameComplement C4-B,Complement component C4B (Childo blood group) 2,Putative uncharacterized protein C4A
UniprotKB Entry NameCO4B_HUMAN,CO4B_HUMAN,NA
FluidUrine,Urine,Urine
M/ZNA,NA,NA
ChargeNA,NA,NA
Mass (in Da)NA,NA,NA
fdrNA,NA,NA
Profiling TechniqueNano-LC-MS,Nano-LC-MS,Nano-LC-MS
Peptide Identification techniqueMS/MS,MS/MS,MS/MS
Quantification TechniqueNA,NA,NA
Labelled/Label FreeLabel Free,Label Free,Label Free
FDR0.01,0.01,0.01
CancerPDF_ID CancerPDF_ID7353, CancerPDF_ID7354, CancerPDF_ID7355,
p-ValueNA,NA,NA
Software"GPM search engine, MASCOT","GPM search engine, MASCOT","GPM search engine, MASCOT"
Length36,36,36
Cancer TypeOvarian cancer,Ovarian cancer,Ovarian cancer
DatabaseIPI 3.71 Human Database ,IPI 3.71 Human Database ,IPI 3.71 Human Database
ModificationNA,NA,NA
Number of Patients6 Ovarian cancer patients and 6 normal individuals,6 Ovarian cancer patients and 6 normal individuals,6 Ovarian cancer patients and 6 normal individuals
RegulationUniquely present in case of urine of ovarian cancer patients,Uniquely present in case of urine of ovarian cancer patients,Uniquely present in case of urine of ovarian cancer patients
ValidationNA,NA,NA
SensitivityNA,NA,NA
SpecificityNA,NA,NA
AccuracyNA,NA,NA
Peptide AtlasNA
IEDB